{"id":"W2078035712","doi":"10.2147/vhrm.s55246","title":"Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk","year":2014,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Janssen Research and Development; Bayer HealthCare","keywords":"Rivaroxaban; Medicine; Atrial fibrillation; Warfarin; Intensive care medicine; Stroke (engine); Dosing; Dabigatran; Anticoagulant; Apixaban; Edoxaban; Clinical trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008568783,0.001536464,0.002588704,0.003423057,0.0006724265,0.001988313,0.002957639,0.005935977,0.006881545],"category_scores_gemma":[0.02257955,0.0009239003,0.002119123,0.002867204,0.001397869,0.003938083,0.001306161,0.005441355,0.003663206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0014014,"about_ca_system_score_gemma":0.006322576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003405639,"about_ca_topic_score_gemma":0.008364495,"domain_scores_codex":[0.9931886,0.002858365,0.002014495,0.0003061074,0.001513155,0.0001192597],"domain_scores_gemma":[0.9915765,0.004895454,0.001208526,0.0002062783,0.001897012,0.0002162576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001408215,0.0001415061,0.0005357181,0.05676531,0.0004819925,0.0004936307,0.000657687,0.0005420728,0.0007712318,0.009784987,0.2449596,0.6847253],"study_design_scores_gemma":[0.0003068398,0.0001119101,0.001626874,0.101984,0.0008267336,0.001339517,0.0005627546,0.0003865267,0.0002791172,0.02068865,0.8717973,0.00008984542],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006380713,0.8970301,0.00693497,0.07993376,0.003622679,0.0006025237,0.0006524895,0.0001948547,0.01039054],"genre_scores_gemma":[0.005370753,0.8986197,0.05786855,0.03174239,0.001370074,0.0008222759,0.0007327995,0.00004413062,0.003429381],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008568783,"threshold_uncertainty_score":0.04531658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05452617617708271,"score_gpt":0.3750624257402439,"score_spread":0.3205362495631612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}